Y-Mabs Therapeutics, Inc. (YMAB)

Last Three Months

25-Jan-24 -- 24-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

16

0

2

+1

0

+2

0

+3

Two Year Chart

25-Apr-22 -- 24-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
07-Mar-24 4:59 PM View:	05-Mar-24 Private Sale ($27.84K)	Smith Susan Laura SVP & CHIEF COMMERCIAL OFFICER		Y-Mabs Therapeutics, Inc. - YMAB	(5%) 35.6K to 33.92K	0	0	--	--	Show Txns Hide Txns

07-Mar-24 5:02 PM View:	05-Mar-24 Private Sale ($28.28K)	Rajah Vignesh SVP & CHIEF MEDICAL OFFICER		Y-Mabs Therapeutics, Inc. - YMAB	(4%) 39.87K to 38.16K	0	0	--	--	Show Txns Hide Txns

14-Feb-24 4:30 PM View:	12-Feb-24 Grant 0	Rossi Michael J President & CEO Director		Y-Mabs Therapeutics, Inc. - YMAB	100% 0 to 35.7K	0	0	--	--	Show Txns Hide Txns

07-Mar-24 5:01 PM View:	05-Mar-24 Private Sale ($64.12K)	Gad Thomas Chief Business Officer Director		Y-Mabs Therapeutics, Inc. - YMAB	(1%) 487.63K to 483.73K	0	0	--	--	Show Txns Hide Txns

14-Mar-24 5:01 PM View:	12-Mar-24 Grant 0	Tagliaferri Mary Director		Y-Mabs Therapeutics, Inc. - YMAB	100% 0 to 4.66K	0	0	--	--	Show Txns Hide Txns